Kaye, Donald
April 2003
Clinical Infectious Diseases;4/1/2003, Vol. 36 Issue 7, pi
Academic Journal
Cites a report presented by researcher Carolyn Masters William at the tenth conference on retroviruses infections in Boston, Massachusetts revealing that Hepatitis G virus protects against HIV progression. Survival rate of HIV-positive persons who were persistently positive for GBV-C; Effect of GBV-C virus on antiretroviral drugs and CCR5 coreceptors.


Related Articles

  • Viral Coinfections among African Children Infected with Human Immunodeficiency Virus Type 1. Chakroborty, Rana; Rees, Gareth; Bourboulia, Dimitra; Cross, Alexandra M.; Dixon, Jedediah R.; D'Agostino, Angelo; Musoke, Rachel; Boshoff, Chris; Rowland-Jones, Sarah L.; Klenerman, Paul // Clinical Infectious Diseases;4/1/2003, Vol. 36 Issue 7, p922 

    City-dwelling children from Kenya who were infected with human immunodeficiency virus type 1 (HIV-1) were tested for coinfection with cytomegalovirus (CMV), human T cell lymphotropic viruses 1 and 2, Kaposi sarcoma-associated herpesvirus (KSHV), or hepatitis B, C, and G viruses. All children...

  • Recombinant GBV-C E2 protein in CD4 count leaves cells tolerant, HIV-resistant. DeNyse, Ashley; Fisher, Stacey L.; Henry, Jennifer // Infectious Disease News;Nov2011, Vol. 24 Issue 11, p33 

    The article reports on a study which found an association between recombinant GB virus C, formerly known as hepatitis G and increased survival among patients with HIV.

  • GBV-C/HGV mucosal transmission.  // AIDS Patient Care & STDs;Dec98, Vol. 12 Issue 12, p943 

    Details findings of a study by researchers at the University of Hawaii which shows a high prevalence of GB virus (GBV) C/hepatitis G virus (HGV) in homosexual men with HIV infection. Transmission of GBC/hepatitis G through mucosal route; Susceptibility of a receptive partner to GBV-C/HGV.

  • Clearance of Hepatitis G viremia in a Human Immunodeficiency Virus--Positive Patient by... Toyoda, Hidenori; Fukuda, Yoshihide; Takamatsu, Junki // Clinical Infectious Diseases;11/1/1999, Vol. 29 Issue 5, p1332 

    Discusses the clearance of hepatitis G viremia in a human immunodeficiency virus (HIV)-positive patient by high-activity antiretroviral therapy (HAART). Diagnosis for a 40-year-old HIV-positive man; Protease inhibitor therapy for the patient; Association of coinfection with HIV with persistent...

  • Hepatitis G Virus and Human Immunodeficiency Virus Coinfection: Response to Interferon-α Therapy. Lau, Daryl T.-Y.; Miller, Kirk D.; Detmer, Jill; Kolberg, Janice; Herpin, Betsey; Metcalf, Julia A.; Davey, Richard T.; Hoofnagle, Jay H. // Journal of Infectious Diseases;10/1/99, Vol. 180 Issue 4, p1334 

    Determines the prevalence and consequences of hepatitis G virus (HGV) infection in 18 HIV-infected patients who participated in a clinical trial for the interferon-alpha therapy. Measurement of HGV RNA levels; Comparison of pretreatment clinical features; Baseline levels among subjects after...

  • Human Herpesvirus 8--Positive Castleman Disease in Human Immunodeficiency Virus--Infected Patients: The Impact of Highly Active Antiretroviral Therapy. Aaron, Laurent; Lidova, Olivier; Yousry, Cherine; Roudiere, Laurent; Dupont, Bertrand; Viard, Jean Paul // Clinical Infectious Diseases;10/1/2002, Vol. 35 Issue 7, p880 

    Reports on seven case histories of human immunodeficiency virus-infected patients with Castleman disease receiving highly active retroviral therapy. Immune reconstitution; Mean duration of survival; Lymph node biopsies.

  • Taking HIV to HAART Hasn't Solved Zoster. Rutledge, Barbara J. // Dermatology Times;Apr2003, Vol. 24 Issue 4, p29 

    Examines the impact of highly active antiretroviral therapy on HIV-infected individuals in Boston, Massachusetts. Development of complications from herpes zoster infections; Incidence of postherpetic neuralgia; Effects on CD4 cell counts.

  • Initial Virological and Immunologic Response to Highly Active Antiretroviral Therapy Predicts Long-Term Clinical Outcome. Kitchen, Christina M.; Kitchen, Scott G.; Dubin, Jeffrey A.; S. Gottlieb, Michael // Clinical Infectious Diseases;8/15/2001, Vol. 33 Issue 4, p466 

    Little is known about the long-term clinical outcomes for human immunodeficiency virus (HIV)-infected patients who have received highly active antiretroviral therapy (HAART). Determining factors associated with long-term clinical outcomes early in the course of treatment may allow modifications...

  • Perceptions of Health Care among Persons Living with HIV/AIDS Who Are Not Receiving Antiretroviral Medications. Kalichman, Seth C.; Graham, Jeffrey; Luke, Webster; Austin, James // AIDS Patient Care & STDs;May2002, Vol. 16 Issue 5, p233 

    Antiretroviral medications are effective at improving the health and increasing the survival of people living with HIV/AIDS. However, studies have shown that a substantial number of HIV-infected people do not receive antiretroviral treatments. The current study examined the physical and mental...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics